Edition:
United Kingdom

Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

8.30USD
19 Sep 2018
Change (% chg)

$-0.20 (-2.35%)
Prev Close
$8.50
Open
$8.50
Day's High
$8.60
Day's Low
$8.25
Volume
11,741
Avg. Vol
80,465
52-wk High
$15.95
52-wk Low
$6.35

Chart for

About

Cytokinetics, Incorporated is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. It is focused on the discovery and development... (more)

Overall

Beta: 1.84
Market Cap(Mil.): $831.83
Shares Outstanding(Mil.): 53.67
Dividend: --
Yield (%): --

Financials

  CYTK.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.29 -- --
ROI: -7.41 1.78 14.61
ROE: -12.90 3.29 16.33

BRIEF-Cytokinetics Reports Q1 Loss Per Share Of $0.56

* CYTOKINETICS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

26 Apr 2018

Earnings vs. Estimates